| 5-Year Stock Return | Stock currently $387, up 125% from $172 (5 years ago). TTM OP grew 134% ($2.1B→$4.9B incl Q3'26E). P/E(ttm) compressed from 67x to 47x through the cycle. Stock appreciation tracked earnings recovery + AI re-rating — ADI is the quintessential quality compounder in analog. |
| Business Model | STRONG. #2 global analog semiconductor company. Q2 FY26 revenue $3.62B record across Industrial (50%), Automotive (24%), Communications (15%), Consumer (11%). 100K+ products, 125K+ customers. GM 73%, OM 49%, FCF margin 36%. Hybrid fab model; internal capacity doubled vs pre-COVID. |
| Competitive Moat | WIDE Analog design expertise = deep, long-lived advantages (7-15yr industrial, 15-20yr A&D cycles). 100K+ products, high switching costs. No customer >10%. ASPs 4-5x industry avg; competitive substitution effectively zero per management. |
| Past 5-YR Drivers | Maxim acquisition revenue synergies, AI data center power + optical (+90% YoY Q2'26 data center), ATE for AI accelerators, A&D record (15-20yr cycles), gross margin recovery (57%→73%), 60+ years of analog design tenure. |
| Recent Stock Move | Stock at $387, +17% post-print from $318 Q2 close; +97% over 8 quarters from $197 trough (Apr 2024). Revenue reaccelerated from -34% to +37% YoY. TTM OP recovered from $2.1B to $4.24B (+102%). R40 at 75%. Perfect 6/6 scorecard for 4 quarters. Steady, quality-led appreciation. |
| Revenue Trend | FLAT Rev YoY: 37% (Q2'26) → 38% (Q3'26E). |
| Margin Trend | FLAT OM%: 38% (Q2'26) → 38% (Q3'26E). |
| TTM OP Trajectory | DECELERATING TTM OP QoQ: +20% (Q2'26) → +16% (Q3'26E). TTM OP $4,244M. |
| Key Opportunities | Empower Semiconductor IVR + silicon caps for AI XPU power (material 2027 ramp); industrial broadening (ATE/A&D/automation/ETM/energy/healthcare grew >40% in 1H FY26); data center comms +90% YoY (optical + power equal); A&D national-sovereignty multi-year tailwind. |
| Key Risks | Valuation at 47x P/E & 38% OM at top of historical range; cycle position with R40 75% approaching prior peak 78% (Q1'22); memory supply chokepoints flagged by mgmt; Q3 GM ~72.5% likely the local peak (utilization maxed). |
| Catalysts | Q3 FY26 earnings print (Aug 2026) at $3.9B / 49% OM / $3.30 EPS midpoint. Empower deal regulatory close + integration. Q4 FY26 typically up low single digits seasonal. 2027 Empower revenue inflection. Potential Investor Day if scheduled. |
| P/E(ttm) Valuation | ELEVATED at 47x (range 24x-68x). Counter-cyclical: low P/E at peak EPS (24x Q4'22), high P/E at trough (68x Q4'24). Current 47x at top of range even with accelerating TTM OP — prices in 2027+ Empower/AI-power tailwinds + $20B 2030 vision. Limited further expansion room. |